欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4699/001
药品名称Sereflo Ciphaler
活性成分
    • fluticasone propionate 100.0 µg
    • salmeterol xinafoat 50.0 µg
剂型Inhalation powder, pre-dispensed
上市许可持有人Cipla Europe De Keyserlei 58-60 Box 19 Antwerpen 2018 - Belgium
参考成员国 - 产品名称Netherlands (NL)
Sereflo Ciphaler, 50 microgram /100microgram/dosis, inhalatiepoeder, voorverdeeld BP
互认成员国 - 产品名称
    • United Kingdom (GB)
    • Germany (DE)
      Serroflo Ciphaler 50 µg/100 µg, einzeldosiertes Pulver zur Inhalation BP
许可日期2020/12/18
最近更新日期2020/12/21
药物ATC编码
    • R03AK06 salmeterol and fluticasone
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Withdrawn（注：已撤市）
    撤市原因：1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised.
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase